Patents by Inventor Renata JANKOWSKA

Renata JANKOWSKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230374005
    Abstract: Lactivicin compounds of formula (I) and pharmaceutically acceptable salts of the compounds of formula (I) are provided, wherein the compounds comprise antibiotics suitable for use either alone or in combination with ?-lactamase inhibitors and/or additional antibiotics (including ?-lactam and non-?-lactam antibiotics) in the treatment or prevention of bacterial infections.
    Type: Application
    Filed: July 25, 2023
    Publication date: November 23, 2023
    Applicant: FEDORA PHARMACEUTICALS INC.
    Inventors: Renata JANKOWSKA, Sameeh M. SALAMA, Samarendra N. MAITI
  • Patent number: 11780832
    Abstract: Lactivicin compounds of formula (I) and pharmaceutically acceptable salts of the compounds of formula (I) are provided, wherein the compounds comprise antibiotics suitable for use either alone or in combination with ?-lactamase inhibitors and/or other antibiotics (including ?-lactam and non-?-lactam antibiotics) in the treatment or prevention of bacterial infections.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: October 10, 2023
    Assignee: FEDORA PHARMACEUTICALS INC.
    Inventors: Renata Jankowska, Sameeh M. Salama, Samarendra N. Maiti
  • Publication number: 20230149368
    Abstract: Pharmaceutical combinations of LTV-17 (I), a lactivicin derivative, and ?-lactamase inhibitors are provided, wherein the combinations comprise antibacterial agents suitable for use in the treatment or prevention of bacterial infections.
    Type: Application
    Filed: November 10, 2022
    Publication date: May 18, 2023
    Applicant: FEDORA PHARMACEUTICALS INC.
    Inventors: Sameeh M. SALAMA, Samarendra N. MAITI, Renata JANKOWSKA
  • Publication number: 20220324858
    Abstract: Lactivicin compounds of formula (I) and pharmaceutically acceptable salts of the compounds of formula (I) are provided, wherein the compounds comprise antibiotics suitable for use either alone or in combination with ?-lactamase inhibitors and/or other antibiotics (including ?-lactam and non-?-lactam antibiotics) in the treatment or prevention of bacterial infections.
    Type: Application
    Filed: March 29, 2022
    Publication date: October 13, 2022
    Applicant: FEDORA PHARMACEUTICALS INC.
    Inventors: Renata JANKOWSKA, Sameeh M. SALAMA, Samarendra N. MAITI